UnknownNCT05128760

Impact of Antiphospholipid Antibodies on Thrombin Generation During Sars-CoV2 Infection (TACIT2 Study)

Studying Antiphospholipid syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Central Hospital, Nancy, France
Principal Investigator
Denis G Wahl, MD, PhD
CHRU of Nancy
Intervention
characterization of aPL(diagnostic_test)
Enrollment
161 enrolled
Eligibility
18 years · All sexes
Timeline
2022 – 2024

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT05128760 on ClinicalTrials.gov

Other trials for Antiphospholipid syndrome

Additional recruiting or active studies for the same condition.

See all trials for Antiphospholipid syndrome →

← Back to all trials